Kalaris Therapeutics, Inc. (KLRS)
Kalaris Therapeutics, Inc. (KLRS) Insider Trading
Directors, officers and holders of more than 10% of KLRS report their trades in its stock on SEC Form 4, within two business days. Each row below is one Form 4 transaction line. The one-letter code says what kind of transaction it was: only P (purchase) and S (sale) are open-market or private trades; awards, option exercises, tax withholding and gifts carry other codes.
Recent Form 4 transactions
The 45 most recent of 45 transactions on file: 2 with code P, 2 with code S and 41 with other codes.
| Date | Insider | Title | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Aug 27, 2026 | Vandekop Amy O'Leary | VP, Corporate Controller | A Award | 10,000 | Not measured | Not measured |
| Aug 1, 2026 | KEATING LAURIE | Director | A Award | 18,000 | Not measured | Not measured |
| Jul 20, 2026 | Bayko Liisa Ann | Chief Financial Officer | A Award | 220,000 | Not measured | Not measured |
| Jun 3, 2026 | Hallal David | Director | A Award | 9,000 | Not measured | Not measured |
| Jun 3, 2026 | Ferrara Napoleone | Director | A Award | 9,000 | Not measured | Not measured |
| Jun 3, 2026 | Jovan-Embiricos Morana | Director | A Award | 9,000 | Not measured | Not measured |
| Jun 3, 2026 | PATTERSON LEONE D | Director | A Award | 9,000 | Not measured | Not measured |
| Jun 3, 2026 | Dybbs Michael | Director | A Award | 9,000 | Not measured | Not measured |
| Jun 3, 2026 | ADAMIS ANTHONY P | Director | A Award | 9,000 | Not measured | Not measured |
| Jun 3, 2026 | AKKARAJU SRINIVAS | Director | A Award | 9,000 | Not measured | Not measured |
| May 20, 2026 | AKKARAJU SRINIVAS | Director | J Other | 66,906 | Not measured | Not measured |
| May 20, 2026 | AKKARAJU SRINIVAS | Director | J Other | 14,937 | Not measured | Not measured |
| May 20, 2026 | AKKARAJU SRINIVAS | Director | J Other | 4,471 | Not measured | Not measured |
| May 20, 2026 | AKKARAJU SRINIVAS | Director | P Purchase | 244,300 | $4.83 | $1,179,969 |
| Mar 20, 2026 | Hagen Brett R | Chief Accounting Officer | S Sale | 1,915 | $6.72 | $12,869 |
| Mar 19, 2026 | Hagen Brett R | Chief Accounting Officer | A Award | 60,800 | Not measured | Not measured |
| Mar 19, 2026 | Feinsod Matthew | Chief Medical Officer | A Award | 135,000 | Not measured | Not measured |
| Mar 19, 2026 | Gall Matthew | Chief Financial Officer | A Award | 95,000 | Not measured | Not measured |
| Mar 19, 2026 | Oxtoby Andrew | See Remarks | A Award | 222,000 | Not measured | Not measured |
| Dec 22, 2025 | AKKARAJU SRINIVAS | Director | A Award | 1,500,000 | $10.00 | $15,000,000 |
| Dec 18, 2025 | AKKARAJU SRINIVAS | Director | P Purchase | 479,847 | $10.42 | $5,000,006 |
| Nov 3, 2025 | Gall Matthew | Chief Financial Officer | A Award | 235,000 | Not measured | Not measured |
| Apr 10, 2025 | AKKARAJU SRINIVAS | Director | A Award | 18,000 | Not measured | Not measured |
| Apr 10, 2025 | Hallal David | Director | A Award | 18,000 | Not measured | Not measured |
| Apr 10, 2025 | PATTERSON LEONE D | Director | A Award | 18,000 | Not measured | Not measured |
| Apr 10, 2025 | Hagen Brett R | Chief Accounting Officer | A Award | 50,262 | Not measured | Not measured |
| Apr 10, 2025 | Jovan-Embiricos Morana | Director | A Award | 18,000 | Not measured | Not measured |
| Apr 10, 2025 | Dybbs Michael | Director | A Award | 18,000 | Not measured | Not measured |
| Apr 10, 2025 | PATEL SAMIR CHANDRAKANT | Director | A Award | 18,000 | Not measured | Not measured |
| Apr 10, 2025 | Ferrara Napoleone | Director | A Award | 18,000 | Not measured | Not measured |
| Apr 10, 2025 | Oxtoby Andrew | See Remarks | A Award | 287,000 | Not measured | Not measured |
| Apr 10, 2025 | ADAMIS ANTHONY P | Director | A Award | 18,000 | Not measured | Not measured |
| Apr 10, 2025 | Feinsod Matthew | Chief Medical Officer | A Award | 70,551 | Not measured | Not measured |
| Apr 10, 2025 | Feinsod Matthew | Chief Medical Officer | A Award | 101,000 | Not measured | Not measured |
| Mar 26, 2025 | Hagen Brett R | Chief Accounting Officer | S Sale | 907 | $8.97 | $8,135 |
| Mar 18, 2025 | ADAMIS ANTHONY P | Director | A Award | 19,484 | Not measured | Not measured |
| Mar 18, 2025 | Feinsod Matthew | Chief Medical Officer | A Award | 28,224 | Not measured | Not measured |
| Mar 18, 2025 | PATEL SAMIR CHANDRAKANT | Director | A Award | 105,913 | Not measured | Not measured |
| Mar 18, 2025 | AKKARAJU SRINIVAS | Director | A Award | 11,444,503 | Not measured | Not measured |
| Mar 18, 2025 | Feinsod Matthew | Chief Medical Officer | A Award | 4,030 | Not measured | Not measured |
| Mar 18, 2025 | PATEL SAMIR CHANDRAKANT | Director | A Award | 100,800 | Not measured | Not measured |
| Mar 18, 2025 | PATEL SAMIR CHANDRAKANT | Director | A Award | 252,000 | Not measured | Not measured |
| Mar 18, 2025 | Ferrara Napoleone | Director | A Award | 504,000 | Not measured | Not measured |
| Mar 18, 2025 | ADAMIS ANTHONY P | Director | A Award | 12,989 | Not measured | Not measured |
| Mar 18, 2025 | Oxtoby Andrew | See Remarks | A Award | 476,611 | Not measured | Not measured |
Questions about this data
Which insider transactions are open-market trades?
Code P (open market or private purchase) and code S (open market or private sale). Code F is shares withheld to pay tax on vesting stock, A is an award from the company, M and X are option exercises and G is a gift. None of those is the insider choosing to buy or sell in the market.
How quickly are insider trades reported?
A Form 4 is due before the end of the second business day after the trade. The date shown is the transaction date from the form.
Who has to file Form 4?
Officers, directors and beneficial owners of more than 10% of a class of the company’s registered equity, under Section 16 of the Securities Exchange Act.
Look up any code in the Form 4 transaction code reference, or read Form 4 codes explained.